James E. Flynn, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 434,145 shares at $6.16 ($2.7M) on 2019-05-09, disclosed to the SEC on 2019-05-13.
Open-market sale of $2.7M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.16 | 172,800 | $1.1M | 39.8% |
| 2 | $6.16 | 261,345 | $1.6M | 60.2% |
| Total | $6.16 avg | 434,145 | $2.7M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |